Xanax (Alprazolam)
Alprazolam (Xanax) is a fast-acting benzodiazepine for anxiety; it causes dependence quickly, is dangerous mixed with opioids or alcohol, and counterfeit "Xanax" pills often contain fentanyl.
Overview
Alprazolam, sold under the brand name Xanax, is a fast-acting benzodiazepine prescribed for anxiety and panic disorders. It is a legitimate, widely prescribed medication, but it carries a significant risk of dependence — which can develop within weeks of regular use — and it is among the most commonly counterfeited pills on the illicit market. Because it is short-acting and potent, both its effects and its withdrawal can be more abrupt than with longer-acting benzodiazepines. The greatest present-day danger is on the street: pills sold as "Xanax" outside a licensed pharmacy are frequently pressed counterfeits that may contain little or no alprazolam and instead carry fentanyl, other synthetic opioids, or designer benzodiazepines, in unpredictable amounts.
Source: MedlinePlus; DEA
Chemistry & mechanism of action
Alprazolam enhances the effect of GABA, the brain's main inhibitory neurotransmitter. By amplifying this calming signal it slows central nervous system activity, reducing anxiety and producing sedation and muscle relaxation. The same mechanism is why benzodiazepines are dangerous in overdose and in combination with other depressants: when CNS activity is suppressed too far, breathing slows. With repeated use the brain adapts to the drug's presence, producing tolerance and physical dependence, so the nervous system becomes over-excitable if the drug is suddenly removed — the basis of a withdrawal syndrome that can be medically dangerous.
Source: MedlinePlus; PubChem CID 2118
Effects
Alprazolam reduces anxiety and produces sedation, drowsiness, muscle relaxation, and a sense of calm. Common effects include fatigue, slurred speech, poor coordination, impaired memory and concentration, and slowed reactions; some people experience paradoxical agitation or disinhibition. Effects can impair driving and other tasks requiring alertness. With repeated use, tolerance develops and higher doses are needed for the same effect, and dependence can form quickly. Stopping abruptly after regular use can cause rebound anxiety, insomnia, tremor, and — in more severe cases — dangerous withdrawal including seizures.
Source: MedlinePlus
Risks & harms
Two dangers stand out. The first is combining alprazolam with other depressants: taken with opioids, alcohol, or other sedatives, it compounds the suppression of breathing and is a frequent factor in fatal overdoses — a risk serious enough that regulators carry explicit warnings about benzodiazepine-and-opioid combinations. The second is the counterfeit market: pills sold as Xanax outside a licensed pharmacy are often pressed fakes that may contain fentanyl or other potent opioids in unpredictable, sometimes lethal amounts, with no reliable way to tell by appearance — which is why naloxone (Narcan), over the counter since 2023, is worth having on hand, since these pills can cause an opioid overdose. The third is withdrawal: after regular use, stopping suddenly can trigger seizures and other dangerous symptoms, so discontinuation should be done gradually under medical supervision, not abruptly and alone. If you suspect an opioid overdose from a counterfeit pill, give naloxone and call 911. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.
Source: DEA; FDA; SAMHSA
Legal status (US)
In the United States, alprazolam is a Schedule IV controlled substance under the Controlled Substances Act: it has an accepted medical use and a lower abuse potential than Schedule II or III drugs, but it still carries a recognized risk of abuse and dependence and is available only by prescription, with limits on refills. Possessing or selling it without a valid prescription is illegal, and counterfeit versions are illicit drugs regardless of how they are labeled. Internationally, alprazolam is controlled under United Nations drug conventions, with penalties varying by country. For country-by-country legal detail, see our legality pages.
Source: DEA; UN drug control conventions
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling, because penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With depressants, the danger is over-sedation: if someone is very drowsy, hard to wake, or breathing slowly, treat it as an emergency.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown, pending review”Identity
- PubChem CID
- 2118PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C17H13ClN4PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4PubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- VREFGVBLTWBCJP-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- xanax, bars, alprazolam, Xanax, Niravam, Solanax, Tranquinal, Alplax, Xanor, Alpronax, Xanax XR, RestylPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown, pending review
Effects, risks & interactions
- Effects
- Alprazolam is a short-acting benzodiazepine that enhances the effect of the inhibitory neurotransmitter GABA, quieting nervous-system activity. Prescribed for anxiety and panic disorder, it brings rapid relief of anxiety along with sedation, muscle relaxation and drowsiness. Its fast onset and short duration are part of why it is both effective and heavily misused — the effect arrives quickly and fades relatively soon, which can drive people to redose.PubChem CID 2118 + DailyMed label ↗ · retrieved 2026-06-18
- Risks
- Alprazolam's short action gives it a distinctive risk profile: as each dose wears off, rebound anxiety and interdose withdrawal can push people to take more, and it is tied to strong dependence and one of the harder benzodiazepine withdrawals. On its own it rarely stops breathing — but combined with opioids or alcohol it becomes lethal, the co-depressants stacking into profound sedation and fatal respiratory depression that drives many overdose deaths. Withdrawal after regular use is itself dangerous: stopping abruptly can trigger seizures and be life-threatening, so it must be tapered under medical supervision — unlike opioid withdrawal, which is agonising but rarely deadly. Counterfeit "Xanax" pills bought illicitly frequently contain fentanyl or other benzodiazepines, so their contents cannot be assumed.PubChem CID 2118 + DailyMed label ↗ · retrieved 2026-06-18
- Interactions
- Alprazolam's labelling carries a boxed warning against combining it with opioids: together, benzodiazepines and opioids can cause profound sedation, respiratory depression, coma and death, so the combination should be avoided or reserved for situations with no alternative. The label likewise warns that other CNS depressants — alcohol and sedatives — add to this danger, and that drugs which inhibit the liver enzyme CYP3A4 can push alprazolam levels up.DailyMed §7 / boxed warning ↗
Dosage
Pending medical reviewer
